Inovio Halts Head And Neck Cancer Trials On Safety Concerns
This article was originally published in The Gray Sheet
Executive Summary
Inovio Biomedical prematurely halted a pivotal study investigating its tumor ablation technology in head and neck cancer June 5 after an independent data monitoring committee raised concerns about adverse events
You may also be interested in...
Tumor Ablator Trials Travel Drug Path, But Sponsor Seeks Device Regulation
Genetronics Biomedical is in talks with FDA to pursue clinical development of the MedPulsor tumor ablation system through a device regulatory route
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.